LEMAITRE VASCULAR INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 5, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 3, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 6, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| May 6, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 6, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 26, 2026 | Barrington Research | maintain | Outperform → Outperform | $105 | 56% |
| Feb 26, 2026 | Roth Capital | reiterate | Buy → Buy | $117 | 53% |
| Feb 26, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $94 | 54% |
| Feb 26, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $118 | 47% |
| Feb 20, 2026 | Barrington Research | maintain | Outperform → Outperform | $95 | 56% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $93 | 54% |
| Oct 15, 2025 | Barrington Research | maintain | Outperform → Outperform | $95 | 56% |
| Sep 23, 2025 | Barrington Research | maintain | Outperform → Outperform | $95 | 56% |
| Aug 6, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $95 | 50% |
| Aug 6, 2025 | Barrington Research | upgrade | Market Perform → Outperform | $95 | 56% |
| Jul 22, 2025 | Barrington Research | reiterate | Market Perform → Market Perform | $0 | 56% |
| Feb 28, 2025 | Lake Street | maintain | Buy → Buy | $110 | 47% |
| Feb 28, 2025 | Citizens Capital Markets | maintain | Buy → Buy | $110 | 49% |
| Feb 28, 2025 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Feb 13, 2025 | Wells Fargo | initiate | — → Equal-Weight | $95 | 54% |
| Nov 1, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $93 | 52% |
| Nov 1, 2024 | Barrington Research | maintain | Outperform → Outperform | $93 | 56% |
| Oct 15, 2024 | Cantor Fitzgerald | initiate | — → Neutral | $96 | 50% |
| Sep 20, 2024 | Barrington Research | maintain | Outperform → Outperform | $92 | 56% |
| Aug 20, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $100 | 53% |
| Aug 2, 2024 | Barrington Research | maintain | Outperform → Outperform | $92 | 56% |
| May 3, 2024 | Barrington Research | maintain | Outperform → Outperform | $79 | 56% |
| May 3, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $77 | 53% |
| Apr 26, 2024 | Stifel | upgrade | Hold → Buy | $75 | 53% |
| Feb 28, 2024 | Barrington Research | maintain | Outperform → Outperform | $69 | 56% |
| Feb 6, 2024 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Oct 23, 2023 | JMP Securities | initiate | — → Market Outperform | $60 | 53% |
| Sep 6, 2023 | Oppenheimer | initiate | — → Outperform | $70 | 52% |
| Aug 3, 2023 | Jefferies | downgrade | Buy → Hold | $67 | 52% |
| Aug 2, 2023 | Lake Street | maintain | Buy → Buy | $75 | 47% |
| Aug 2, 2023 | Barrington Research | maintain | Outperform → Outperform | $66 | 56% |
| May 3, 2023 | Barrington Research | upgrade | Market Perform → Outperform | $62 | 56% |
| Oct 28, 2022 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Sep 16, 2021 | Jefferies | initiate | — → Buy | $70 | 52% |
| Aug 3, 2021 | Roth Capital | maintain | — → Neutral | $58 | 53% |
| May 4, 2021 | Roth Capital | maintain | — → Neutral | $55 | 53% |
| Feb 12, 2021 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Oct 30, 2020 | Roth Capital | maintain | — → Neutral | $36 | 53% |
| Jul 24, 2020 | Stifel | maintain | — → Hold | $30 | 53% |
| Jul 24, 2020 | Canaccord Genuity | maintain | — → Hold | $30 | 48% |
| May 4, 2020 | Stifel | maintain | — → Hold | $25 | 53% |
| Apr 14, 2020 | Canaccord Genuity | maintain | — → Hold | $24 | 48% |
| Apr 8, 2020 | Sidoti & Co. | maintain | — → Buy | $34 | 38% |
| Mar 16, 2020 | Sidoti & Co. | upgrade | Neutral → Buy | $38 | 38% |
| Oct 24, 2019 | Lake Street | upgrade | Hold → Buy | $40 | 47% |
No cross-platform signals in the last 90 days